DE69936452D1 - Vogel-polyomavirus impfstoff in papageien - Google Patents

Vogel-polyomavirus impfstoff in papageien

Info

Publication number
DE69936452D1
DE69936452D1 DE69936452T DE69936452T DE69936452D1 DE 69936452 D1 DE69936452 D1 DE 69936452D1 DE 69936452 T DE69936452 T DE 69936452T DE 69936452 T DE69936452 T DE 69936452T DE 69936452 D1 DE69936452 D1 DE 69936452D1
Authority
DE
Germany
Prior art keywords
bird
nucleic acid
avian
parrot
polyomarvirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69936452T
Other languages
English (en)
Inventor
Steven Poet
Branson W Ritchie
Victoria Burnley
Denise Pesti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Georgia
University of Georgia Research Foundation Inc UGARF
Original Assignee
University of Georgia
University of Georgia Research Foundation Inc UGARF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Georgia, University of Georgia Research Foundation Inc UGARF filed Critical University of Georgia
Application granted granted Critical
Publication of DE69936452D1 publication Critical patent/DE69936452D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
    • C12N2710/22022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/22011—Polyomaviridae, e.g. polyoma, SV40, JC
    • C12N2710/22034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition
    • Y10S977/917—Vaccine
DE69936452T 1998-05-04 1999-05-03 Vogel-polyomavirus impfstoff in papageien Expired - Lifetime DE69936452D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/072,634 US6491921B1 (en) 1994-01-13 1998-05-04 Avian polyomavirus vaccines in psittacine birds
PCT/US1999/009690 WO1999056700A2 (en) 1998-05-04 1999-05-03 Avian polyomavirus vaccines in psittacine birds

Publications (1)

Publication Number Publication Date
DE69936452D1 true DE69936452D1 (de) 2007-08-16

Family

ID=22108854

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69936452T Expired - Lifetime DE69936452D1 (de) 1998-05-04 1999-05-03 Vogel-polyomavirus impfstoff in papageien

Country Status (6)

Country Link
US (1) US6491921B1 (de)
EP (1) EP1082011B1 (de)
AT (1) ATE366305T1 (de)
AU (1) AU3970099A (de)
DE (1) DE69936452D1 (de)
WO (1) WO1999056700A2 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5523088A (en) * 1994-01-13 1996-06-04 University Of Georgia Research Foundation, Inc. Inactivated avian polyomavirus vaccine in psittacine birds
US5747045A (en) * 1994-01-13 1998-05-05 University Of Georgia Research Foundation, Inc. Avian polyomavirus vaccine in psittacine birds

Also Published As

Publication number Publication date
EP1082011A2 (de) 2001-03-14
EP1082011A4 (de) 2002-11-04
US6491921B1 (en) 2002-12-10
EP1082011B1 (de) 2007-07-04
ATE366305T1 (de) 2007-07-15
WO1999056700A3 (en) 1999-12-16
AU3970099A (en) 1999-11-23
WO1999056700A2 (en) 1999-11-11

Similar Documents

Publication Publication Date Title
BR9605153B1 (pt) vacina de combinação, e, kit de vacinação.
EP1064024A4 (de) Impfstoffe gegen circovirus infektionen
MX9203458A (es) Segmentos inmunogenicos que contienen glicoproteinas quimericas de las glicoproteinas de virus sincitial respiratorio humano.
BRPI9912663B8 (pt) vacina contra cáncer e polipeptìdeo.
PT719864E (pt) Vacina viva recombinante aviaria usando como vector um herpesvirus aviario
TNSN98015A1 (fr) Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngottracheite infectieuse aviaire
DE602004025579D1 (de) Polypeptide zur induktion einer schützenden immunantwort gegen staphylococcus aureus
CY1106175T1 (el) Αλληλουχιες νουκλεϊνικου οξεος και αμινοξεος μολυσματικου ιου αναιμιας σολομων και χρηση τους ως εμβολια
UA84667C2 (ru) Вакцина, направленная против инфекции, вызванной вирусом герпеса болезни марека
ATE507286T1 (de) Immunisierung von fischen gegen virusinfektion
ATE346931T1 (de) Clostridium perfringens impfstoff
PL338118A1 (en) Bird's retrovirus and method of obtaining same, poultry protecting vaccine and method of obtaining same as well as method of controlling a poultry disease
DK0653489T3 (da) Coccidiosisvaccine til fjerkræ
DE69635472D1 (de) Impfstoff gegen Geflügelkokzidose
WO2005011571A3 (en) Hepatitis virus core proteins as vaccine platforms and methods of use thereof
DK0709460T3 (da) Fjerkrævaccine imod coccidiosis
DE69936452D1 (de) Vogel-polyomavirus impfstoff in papageien
FR2829498B1 (fr) Igf-1 comme adjuvant de vaccin felin, notamment contre les retrovirus felins
WO2000074630A3 (en) Dna vaccine for protecting an avian against infectious bursal disease virus
BR9508645A (pt) Vacina da peritonite infecciosa felina
HUP9802974A1 (hu) Fertőző bursitis elleni DNS-vakcina
HUP0103871A2 (hu) Rekombináns CELO-vírus és CELO vírus DNS
ATE359811T1 (de) Verwendung von trehalose produzierenden prokaryotischen zellen als impfstoffe
TH23870EX (th) วัคซีนและวิธีสำหรับการเตรียม

Legal Events

Date Code Title Description
8332 No legal effect for de